Delivery Order SPE2DB25D3001-SPE2DB25FQUFK

Award Date 3/26/25
Potential Completion Date 3/27/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,310.45, is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a medical product. The contract is a Firm Fixed Price Delivery Order with a completion date of March 12, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,370.39, is a Firm Fixed Price Delivery Order for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a medical product. The contract has a period of performance through January 31, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,124.60, is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML medical supplies. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism, and the ultimate completion date is May 30, 2024. The contract is not designated with a set-aside requirement....
This federal contract award, valued at $7,881.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the product "VAXNEUVANCE 0.5 ML SYRINGE 0.5ML" with a completion date of November 29, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $42,641.71, is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a medical supply. The contract is a Delivery Order with a Firm Fixed Price pricing type, with a completion date of September 25, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,813.72, is a delivery order for the VAXNEUVANCE 0.5 ML SYRINGE 0.5ML product. It has an ultimate completion date of March 4, 2025 and a firm fixed price pricing type. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $2,740.78, is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product. The contract is a firm-fixed-price delivery order with a completion date of January 23, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor and...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $66,637.09 firm fixed-price delivery order is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a medical product. The contract has an ultimate completion date of February 25, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $41,577.47, is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML medical products. The contract has a firm fixed price pricing type and an ultimate completion date of January 17, 2025. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $18,437.52, is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 14, 2023. The contract is not designated as a set-aside....
  • SPE2DB25D3001
    Indefinite Delivery Contract
  • SPE2DB25D3001-SPE2DB25FQUFK
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,080.35, is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a medical product. The contract has a firm fixed price and an ultimate completion date of March 27, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/29/25, 1:30 AM